Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 1, 2009, Pages 204-210

  Bauzo, Rayna M ^a   Kimmel, Heather L ^a,b   Howell, Leonard L ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caudate nucleus; Cocaine; Dopamine; LY379268; mGluR2 3; Microdialysis; Operant behavior; Reinstatement; Self administration; Stimulant

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; COCAINE; DOPAMINE; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; DRUG SELF ADMINISTRATION; EXTRACELLULAR SPACE; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SQUIRREL MONKEY; STIMULUS;

AMINO ACIDS; ANIMALS; BEHAVIOR, ANIMAL; BICYCLO COMPOUNDS, HETEROCYCLIC; CAUDATE NUCLEUS; COCAINE; CONDITIONING (PSYCHOLOGY); DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXTINCTION, PSYCHOLOGICAL; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; MALE; MICRODIALYSIS; REACTION TIME; RECEPTORS, METABOTROPIC GLUTAMATE; REINFORCEMENT SCHEDULE; SAIMIRI; SELF ADMINISTRATION; TIME FACTORS;

PRIMATES; SAIMIRI;

EID: 70349216322     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.08.011     Document Type: Article

References (41)

1. Adewale A.S., Platt D.M., and Spealman R.D. Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys. J Pharmacol Exp Ther 318 (2006) 922-931
2. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.C., Toda S., et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6 (2003) 743-749
3. Bossert J.M., Busch R.F., and Gray S.M. The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 16 (2005) 1013-1016
4. Cartmell J., Monn J.A., and Schoepp D.D. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291 (1999) 161-170
5. Cartmell J., Monn J.A., and Schoepp D.D. The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing. Eur J Pharmacol 400 (2000) 221-224
6. Cartmell J., Salhoff C.R., Perry K.W., Monn J.A., and Schoepp D.D. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum. Brain Res 887 (2000) 378-384
7. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37 (1997) 205-237
8. Corti C., Battaglia G., Molinaro G., Riozzi B., Pittaluga A., Corsi M., et al. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. J Neurosci 27 (2007) 8297-8308
9. Czoty P.W., Justice Jr. J.B., and Howell L.L. Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys. Psychopharmacology (Berl) 148 (2000) 299-306
10. David H.N., and Abraini J.H. Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. Neuropharmacology 44 (2003) 717-727
11. Fell M.J., Svensson K.A., Johnson B.G., and Schoepp D.D. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 326 (2008) 209-217
12. Gergen J.A., MacLean P.D., and National Institutes of Health (U.S.). A stereotaxic atlas of the squirrel monkey's brain (Saimiri sciureus). Bethesda, Md.: U.S. Dept. of Health Education and Welfare Public Health Service National Institutes of Health (1962)
13. Ginsburg B.C., Kimmel H.L., Carroll F.I., Goodman M.M., and Howell L.L. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys. Pharmacol Biochem Behav 80 (2005) 481-491
14. Greenslade R.G., and Mitchell S.N. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell. Neuropharmacology 47 (2004) 1-8
15. Grillon C., Cordova J., Levine L.R., and Morgan III C.A. Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans. Psychopharmacology (Berl) 168 (2003) 446-454
16. Gupta D.S., McCullumsmith R.E., Beneyto M., Haroutunian V., Davis K.L., and Meador-Woodruff J.H. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse 57 (2005) 123-131
17. Howell L.L., and Wilcox K.M. Methods of Behavior Analysis in Neuroscience (2001), CRC Press, Boca Raton
18. Hu G., Duffy P., Swanson C., Ghasemzadeh M.B., and Kalivas P.W. The regulation of dopamine transmission by metabotropic glutamate receptors. J Pharmacol Exp Ther 289 (1999) 412-416
19. Kim J.H., Austin J.D., Tanabe L., Creekmore E., and Vezina P. Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Eur J Neurosci 21 (2005) 295-300
20. Kimmel H.L., Ginsburg B.C., and Howell L.L. Changes in extracellular dopamine during cocaine self-administration in squirrel monkeys. Synapse 56 (2005) 129-134
21. Kimmel H.L., O'Connor J.A., Carroll F.I., and Howell L.L. Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav 86 (2007) 45-54
22. Moghaddam B. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 174 (2004) 39-44
23. Moghaddam B., and Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281 (1998) 1349-1352
24. Monn J.A., Valli M.J., Massey S.M., Hansen M.M., Kress T.J., Wepsiec J.P., et al. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobiclo[3.1.0] hexane-2,6-dicarbocylic acid (LY354740): identification of two new potent, selective and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 42 (1999) 1027-1040
25. Muly E.C., Mania I., Guo J.D., and Rainnie D.G. Group II metabotropic glutamate receptors in anxiety circuitry: correspondence of physiological response and subcellular distribution. J Comp Neurol 505 (2007) 682-700
26. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 13 (1994) 1031-1037
27. Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D., et al. Glutamate receptors: brain function and signal transduction. Brain Res Brain Res Rev 26 (1998) 230-235
28. O'Neill M.F., Heron-Maxwell C., Conway M.W., Monn J.A., and Ornstein P. Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice. Neuropharmacology 45 (2003) 565-574
29. Ohishi H., Shigemoto R., Nakanishi S., and Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335 (1993) 252-266
30. Ohishi H., Ogawa-Meguro R., Shigemoto R., Kaneko T., Nakanishi S., and Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex. Neuron 13 (1994) 55-66
31. Peters J., and Kalivas P.W. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats. Psychopharmacology (Berl) 186 (2006) 143-149
32. Pierce R.C., Bell K., Duffy P., and Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16 (1996) 1550-1560
33. Pin J.P., and Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995) 1-26
34. Pintor A., Tiburzi F., Pezzola A., and Volpe M.T. Metabotropic glutamate receptor agonist (1S,3R-ACPD) increased frontal cortex dopamine release in aged but not in young rats. Eur J Pharmacol 359 (1998) 139-142
35. Seeman P., Caruso C., and Lasaga M. Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268. Synapse 62 (2008) 154-158
36. Spealman R.D., Lee B., Tiefenbacher S., Platt D.M., Rowlett J.K., and Khroyan T.V. Triggers of relapse: nonhuman primate models of reinstated cocaine seeking. Nebr Symp Motiv 50 (2004) 57-84
37. Taber M.T., and Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J Neurosci 15 (1995) 3896-3904
38. Testa C.M., Friberg I.K., Weiss S.W., and Standaert D.G. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. J Comp Neurol 390 (1998) 5-19
39. Watkins J.C. l-glutamate as a central neurotransmitter: looking back. Biochem Soc Trans 28 (2000) 297-309
40. Xi Z.X., Ramamoorthy S., Baker D.A., Shen H., Samuvel D.J., and Kalivas P.W. Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine. J Pharmacol Exp Ther 303 (2002) 608-615
41. Xi Z.X., Baker D.A., Shen H., Carson D.S., and Kalivas P.W. Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. J Pharmacol Exp Ther 300 (2002) 162-171